R&D Meets M&A contains edited papers given by a group of senior executives, chief technology officers, economists, and business analysts at the Chemical Heritage Foundation on 29 April 2003. Together, these papers make the case that successful mergers require an expanded role for research divisions and should be driven by compatible innovation cultures. Looking to the future, only a combination of greater in-house R&D and increased use of joint ventures will improve the chemical industry's competitive standing, as it copes with emerging new markets and competing science-based businesses.

About the Editor:
Arthur Daemmrich is an assistant professor in Business, Government, and International Economy at Harvard Business School and a Senior Research Fellow at the Chemical Heritage Foundation. He holds a Ph.D. in science and technology studies from Cornell University and has published on biotechnology policy and politics, the sociology of medicine, and pharmaceutical drug regulation. He is the author of Pharmacopolitics: Drug Regulation in the United States and Germany.